Sewoon Medical Co Ltd

Business Summary Sewoon Medical Co Ltd is a Korea-based company engaged in the manufacture, import, and sale of consumable medical devices, including wound drainage systems, urinary catheters, drainage catheters, tracheal tubes, and infusion devices. --- # Classification Summary Sewoon Medical Co Ltd is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Medical Equipment, Supplies & Distribution industry, with a classification confidence of 0.92. --- # Narrative Sewoon Medical maintains a strong liquidity position, with a current ratio of 14.58 and cash and equivalents amounting to 97,022,857,740 KRW, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal leverage. Profitability metrics show Sewoon Medical is performing well relative to industry norms. The company's return on equity (ROE) is 7.88%, and return on assets (ROA) is 7.27%, both of which are strong indicators of efficient capital use and asset management. The company's revenue is primarily derived from the sale of medical devices, with no disclosed segment or geographic breakdown. However, the company is based in Korea, suggesting a potential concentration in the domestic market. No specific revenue concentration data is provided, but the lack of segment details implies a need for further analysis. Sewoon Medical's growth trajectory is supported by a strong operating cash flow of 17,773,229,960 KRW and a free cash flow of 11,209,207,800 KRW. The company's capital expenditure of -1,699,311,380 KRW indicates a reduction in investment, which may signal a focus on maintaining current operations rather than expansion. The company's risk profile is low, with no immediate filing-based liquidity or dilution flags detected. The low dilution risk is further supported by the absence of significant changes in shares outstanding between basic and diluted figures. Recent financial filings and transcripts do not indicate any major events or strategic shifts. The company's last actual EPS was 323.00 KRW, suggesting stable earnings performance. --- # Key Takeaways - Sewoon Medical has a strong liquidity position with a high current ratio and substantial cash reserves. - The company demonstrates strong profitability with high ROE and ROA. - The company's capital structure is conservative, with minimal debt. - Growth appears to be driven by strong operating and free cash flows. - The company's risk profile is low, with no immediate liquidity or dilution concerns. --- # Rationales ```json { "margin_outlook_rationale": "Stable gross and operating margins are expected due to consistent revenue and cost management.", "rd_outlook_rationale": "No specific R&D investment data is available, but the company's product portfolio suggests ongoing innovation.", "capex_outlook_rationale": "Capital expenditure is expected to remain low as the company focuses on maintaining current operations.", "revenue_outlook_rationale": "Revenue is expected to grow steadily due to strong operating cash flow and market demand for medical devices.", "segment_outlook": {}, "dilution_sources": [], "dilution_near_term_probability": "low", "dilution_expected_timeframe": "no near-term pressure", "concentration_risk": "medium", "regulatory_risk": "low", "liquidity_risk_rationale": "The company has a strong liquidity position with a high current ratio and substantial cash reserves.", "credit_risk_rationale": "The company's low debt-to-equity ratio and strong cash flow position reduce credit risk." } ``` --- # Inversion (DS-6) ```json { "bull_to_bear_signals": [ { "signal_id": "bull-to-bear-1", "signal": "Operating cash flow declines by more than 50% year-over-year", "monitorable_field": "financial_snapshot.operating_cash_flow", "threshold": "yoy_pct < -50", "rationale": "A significant decline in operating cash flow could indicate operational challenges or reduced demand." }, { "signal_id": "bull-to-bear-2", "signal": "Free cash flow becomes negative", "monitorable_field": "financial_snapshot.free_cash_flow", "threshold": "free_cash_flow < 0", "rationale": "Negative free cash flow could signal financial stress and reduced ability to fund operations or growth." } ], "bear_to_bull_signals": [ { "signal_id": "bear-to-bull-1", "signal": "Operating cash flow increases by more than 50% year-over-year", "monitorable_field": "financial_snapshot.operating_cash_flow", "threshold": "yoy_pct > 50", "rationale": "A significant increase in operating cash flow could indicate improved operational efficiency or increased demand." }, { "signal_id": "bear-to-bull-2", "signal": "Free cash flow increases by more than 50% year-over-year", "monitorable_field": "financial_snapshot.free_cash_flow", "threshold": "yoy_pct > 50", "rationale": "A significant increase in free cash flow could signal improved financial health and greater capacity for growth or dividends." } ] } ``` --- # Self Scoring ```json { "business_understanding_score": 0.95, "economics_quality_score": 0.90, "ten_year_visibility_score": 0.85, "competitive_landscape_visibility_score": 0.80 } ```